D.E. Shaw & Co
TTPH

D.E. Shaw & Co’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

D.E. Shaw & Co’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,300
Closed -$72K – 4115
2018
Q3 		$72K Sell
1,300
-401
-24% -$25.6K ﹤0.01% 3637
2018
Q2 		$121K Buy
1,701
+371
+28% +$26.2K ﹤0.01% 3599
2018
Q1 		$82K Sell
1,330
-26,252
-95% -$2.3M ﹤0.01% 3403
2017
Q4 		$3.48M Sell
27,582
-2,058
-7% -$264K ﹤0.01% 1748
2017
Q3 		$4.05M Buy
29,640
+23,124
+355% +$3.09M 0.01% 1527
2017
Q2 		$930K Buy
6,516
+200
+3% +$30.9K ﹤0.01% 2462
2017
Q1 		$1.16M Sell
6,316
-1,887
-23% -$212K ﹤0.01% 2207
2016
Q4 		$661K Sell
8,203
-1,424
-15% -$113K ﹤0.01% 2706
2016
Q3 		$737K Buy
+9,627
New +$771K ﹤0.01% 2588
2016
Q1 		– Sell
-4,294
Closed -$861K – 3918
2015
Q4 		$861K Buy
4,294
+2,446
+132% +$488K ﹤0.01% 2749
2015
Q3 		$276K Buy
1,848
+1,460
+376% +$1.07M ﹤0.01% 3376
2015
Q2 		$368K Sell
388
-22
-5% -$18K ﹤0.01% 3324
2015
Q1 		$300K Buy
+410
New +$308K ﹤0.01% 3301
2013
Q3 		– Sell
-909
Closed -$128K – 4531
2013
Q2 		$128K Buy
+909
New +$144K ﹤0.01% 3840

Other funds holding TTPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.E. Shaw & Co's TTPH Position: Q4 2018 in Review

D.E. Shaw & Co sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2018, closing a stake of 1,300 shares — an estimated $72K sold.

D.E. Shaw & Co first reported a position in TTPH in Q2 2013 and held it in 14 quarters. The position peaked at $4.05M in Q3 2017. 86 funds tracked by Wall St. Rank hold TTPH as of Q4 2018.

  • D.E. Shaw & Co reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,300 Tetraphase Pharmaceuticals, Inc. shares in Q4 2018, an estimated $72K.
  • D.E. Shaw & Co first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 14 quarters.
  • D.E. Shaw & Co's Tetraphase Pharmaceuticals, Inc. position peaked at $4.05M in Q3 2017.
  • 86 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2018.

Based on D.E. Shaw & Co's 13F filing for Q4 2018, filed 14 Feb 2019.